xCARE, Developer of Expert Platform for Pharmaceutical and Medical Device Development, Raises ¥600 Million in Series A Funding
AI Summary (NQ-processed)
xCARE, which operates an expert platform specialized in pharmaceutical and medical device development, has successfully raised a total of ¥600 million in its Series A funding round. The funds will be used to enhance platform features, expand its talent network, and strengthen internal operations, aiming to build infrastructure for the life sciences sector.
AI Analysis
Frequently Asked Questions
Q: What specific services does xCARE offer?
A: It provides outsourced services that allow clients to utilize highly specialized professionals needed for pharmaceutical and medical device development on a project basis, as needed.
Q: Why is this funding round significant?
A: It addresses the shortage of specialized talent in the life sciences sector and raises expectations for building infrastructure that accelerates innovation.
Q: How many registered professionals does xCARE's platform have?
A: Approximately 2,500 professionals registered as freelancers or holding side jobs are available.